Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 17 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 8669081

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 11, 2014 · Expires Mar 6, 2034

    granted
  2. US 8663936

    Sodium channel protein type III α-subunit splice variant

    Vertex Pharmaceuticals Incorporated · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  3. US 8664219

    Aminopyrimidines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  4. US 8664273

    Treatment of hepatitis C virus with telaprevir (VX-950) in patients non-responsive to treatment with pegylated interferon-alpha 2A/2B and ribavirin

    Vertex Pharmaceuticals Incorporated · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  5. US 8658674

    Thiophene analogues for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  6. US 8653103

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  7. US 8653088

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  8. US 8642779

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted
  9. US 8637457

    Processes and intermediates

    Vertex Pharmaceuticals Incorporated · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted
  10. US 8637511

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted
  11. US 8637666

    Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted
  12. US 8633189

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted
  13. US 8633210

    Triazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted
  14. US 8633205

    Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted
  15. US 8629162

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted
  16. US 8623905

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted
  17. US 8623894

    Solid forms of N-[2,4-Bis(1,1-dimethyethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquioline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted
  18. US 8623869

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted
  19. US 8618152

    Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases

    Vertex Pharmaceuticals Incorporated · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted
  20. US 8618106

    Protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted
  21. US 8614327

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted
  22. US 8614325

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted
  23. US 8609703

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted
  24. US 8604203

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted